News
There could be an upside to incorporating AI for the FDA. Using AI to assist in final drug reviews would "represent a chance ...
Jeremy Walsh, who was recently named as the FDA's first-ever AI officer, has reportedly led the discussions with OpenAI, but so far, "no contract has been signed." 'Broader trend of AI adoption in ...
Lantern Pharma's Q1 2025 earnings reveal clinical progress, AI commercialization plans, and financial discipline.
The success of AI in healthcare is influenced more by human factors and organizational readiness than by the technology ...
Guest blog from Laura Foster, Associate Director for Technology and Innovation at techUK , as part of our ...
Stuart J. Schnitt, MD, discussed how AI enhances cancer diagnoses and the need for professional oversight, ethical clarity, and equitable adoption.
We recently published a list of the 10 Most Popular AI Stocks to Avoid Now. In this article, we are going to take a look at ...
Monogram Technologies Inc (MGRM) secures FDA clearance for its TKA system, while navigating competitive pressures and planning a strategic rollout.
GE HealthCare (Nasdaq: GEHC) today announced the launch of its CleaRecon DL technology for enhancing CBCT imaging.
The unintentional theme of today’s issue is the struggle for control over how we implement AI in the U.S. On one side, where ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results